Epilepsy and Cannabis
Regulator-approved cannabidiol uses in specific epilepsy syndromes, relevant controlled trials, and the limits of generalising those findings to other products or seizure disorders.
- Duration
- 40 minutes + quiz
- Instructor
- Prof Mike Barnes (United Kingdom)
- Learning format
- Module
- Status
- Available now
12-month access from confirmed payment. Certificate of completion included.
One-time payment in USD. Access begins after confirmed payment and continues for 12 months. Refunds are available before access begins, subject to mandatory consumer rights.
Purchase ModuleBy selecting Purchase Module, you acknowledge the Terms and Conditions, including USD pricing, applicable taxes, the pre-access refund policy and 12-month access period.
A certificate records completion only; it is not a qualification, licence, specialist credential or accreditation. Read the complete Terms and Conditions.
Educational content only. Not medical advice. Practitioners are responsible for compliance with local law.
Regulator-approved cannabidiol uses in specific epilepsy syndromes, relevant controlled trials, and the limits of generalising those findings to other products or seizure disorders.
- Describe regulator-approved cannabidiol uses for specific epilepsy syndromes.
- Distinguish evidence for defined pharmaceutical formulations from claims about cannabis products generally.
- 01Recorded lecture
A 40-minute lecture delivered by the module educator.
- 02Assessment quiz
A short quiz assessing understanding of the key learning points.
Is this module part of a course?+
No — this is a standalone specialised module.
When can I access it?+
This module is available now. Access begins after confirmed payment and continues for 12 months.
Are certificates provided?+
A certificate of completion records completion of the educational activity. It is not a professional qualification, licence, specialist credential or accreditation unless expressly stated otherwise.